Literature DB >> 35079125

TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc.

Jianfeng Liu1,2, Ruyan Wu1, Robert Seaman1, Kevin M Manz3, Bernard Johnson1, Jimmy Vu1, Yufei Huang1, Yanan Zhang4, Alfred J Robison5,6, Rachael Neve7, Brad A Grueter3, David Dietz1, Jun-Xu Li8.   

Abstract

Relapse remains a major challenge to the treatment of cocaine addiction. Recent studies suggested that the trace amine-associated receptor 1 (TAAR1) could be a promising target to treat cocaine addiction and relapse; however, the underlying mechanism remains unclear. Here, we aimed to investigate the neural mechanism underlying the role of TAAR1 in the drug priming-induced reinstatement of cocaine-seeking behavior in rats, an animal model of cocaine relapse. We focused on the shell subregion of nucleus accumbens (NAc), a key brain region of the brain reward system. We found that activation of TAAR1 by systemic and intra-NAc shell administration of the selective TAAR1 agonist RO5166017 attenuated drug-induced reinstatement of cocaine-seeking and prevented drug priming-induced CaMKIIα activity in the NAc shell. Activation of TAAR1 dampened the CaMKIIα/GluR1 signaling pathway in the NAc shell and reduced AMPAR-EPSCs on the NAc slice. Microinjection of the selective TAAR1 antagonist EPPTB into the NAc shell enhanced drug-induced reinstatement as well as potentiated CaMKIIα activity in the NAc shell. Furthermore, viral-mediated expression of CaMKIIα in the NAc shell prevented the behavioral effects of TAAR1 activation. Taken together, our findings indicate that TAAR1 regulates drug-induced reinstatement of cocaine-seeking by negatively regulating CaMKIIα activity in the NAc. Our findings elucidate a novel mechanism of TAAR1 in regulating drug-induced reinstatement of cocaine-seeking and further suggests that TAAR1 is a promising target for the treatment of cocaine relapse.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35079125     DOI: 10.1038/s41380-022-01448-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  39 in total

Review 1.  Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.

Authors:  Michael D Schwartz; Juan J Canales; Riccardo Zucchi; Stefano Espinoza; Ilya Sukhanov; Raul R Gainetdinov
Journal:  Expert Opin Ther Targets       Date:  2018-06-05       Impact factor: 6.902

2.  Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.

Authors:  D Leo; L Mus; S Espinoza; M C Hoener; T D Sotnikova; R R Gainetdinov
Journal:  Neuropharmacology       Date:  2014-02-22       Impact factor: 5.250

Review 3.  Circuit and Synaptic Plasticity Mechanisms of Drug Relapse.

Authors:  Yan Dong; Jane R Taylor; Marina E Wolf; Yavin Shaham
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

Review 4.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

5.  Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.

Authors:  Florent G Revel; Claas A Meyer; Amyaouch Bradaia; Karine Jeanneau; Eleonora Calcagno; Cédric B André; Markus Haenggi; Marie-Thérèse Miss; Guido Galley; Roger D Norcross; Roberto W Invernizzi; Joseph G Wettstein; Jean-Luc Moreau; Marius C Hoener
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

6.  Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.

Authors:  Jian-Feng Liu; Justin N Siemian; Robert Seaman; Yanan Zhang; Jun-Xu Li
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

7.  TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.

Authors:  Florent G Revel; Jean-Luc Moreau; Raul R Gainetdinov; Amyaouch Bradaia; Tatyana D Sotnikova; Roland Mory; Sean Durkin; Katrin Groebke Zbinden; Roger Norcross; Claas A Meyer; Veit Metzler; Sylvie Chaboz; Laurence Ozmen; Gerhard Trube; Bruno Pouzet; Bernhard Bettler; Marc G Caron; Joseph G Wettstein; Marius C Hoener
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-27       Impact factor: 11.205

8.  Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.

Authors:  David A Thorn; Li Jing; Yanyan Qiu; Amy M Gancarz-Kausch; Chad M Galuska; David M Dietz; Yanan Zhang; Jun-Xu Li
Journal:  Neuropsychopharmacology       Date:  2014-04-18       Impact factor: 7.853

9.  Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking.

Authors:  Yui Pei; Jungah Lee; Damiana Leo; Raul R Gainetdinov; Marius C Hoener; Juan J Canales
Journal:  Neuropsychopharmacology       Date:  2014-04-11       Impact factor: 7.853

Review 10.  The treatment of cocaine use disorder.

Authors:  Kyle M Kampman
Journal:  Sci Adv       Date:  2019-10-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.